1994
DOI: 10.1007/bf00686279
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic enhancement of doxorubicin cytotoxicity

Abstract: Argon ion laser irradiation at 514.1 nm and 488 nm dramatically increased doxorubicin cytotoxicity in an L929 cell clonogenic survival assay. The cytotoxicity was dependent on both the drug concentration and the total light energy delivered such that at 5 micrograms doxorubicin/ml and 800 J/cm2, cytotoxicity was enhanced by a factor of > 10(4) relative to that achieved with drug alone. Irradiation times in excess of 2 min and power densities in excess of 100 J/cm2 were required to produce the effect. Beyond th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

1997
1997
2020
2020

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 8 publications
0
17
0
Order By: Relevance
“…Although we observed minor photocytotoxic effect of aclarubicin with conjunction with LPL compared to the phototoxic effects reported previously for other anthracyclines (Brophy and Keller, 1992;Canti et al, 1998;Lanks et al, 1994;Paiva et al, 1996Paiva et al, , 1998 it seems that aclarubicin might be considered as a good candidate for combined PDT, especially as in contrast to other anthracyclines (doxorubicin, daunorubicin) it displays considerably lower cardiotoxicity (Natale et al, 1993). Aclarubicin strongly absorbs light in the long wavelength region of the visible spectra, which also theoretically makes this drug a good candidate as a photosensitizer.…”
Section: Discussionmentioning
confidence: 53%
See 1 more Smart Citation
“…Although we observed minor photocytotoxic effect of aclarubicin with conjunction with LPL compared to the phototoxic effects reported previously for other anthracyclines (Brophy and Keller, 1992;Canti et al, 1998;Lanks et al, 1994;Paiva et al, 1996Paiva et al, , 1998 it seems that aclarubicin might be considered as a good candidate for combined PDT, especially as in contrast to other anthracyclines (doxorubicin, daunorubicin) it displays considerably lower cardiotoxicity (Natale et al, 1993). Aclarubicin strongly absorbs light in the long wavelength region of the visible spectra, which also theoretically makes this drug a good candidate as a photosensitizer.…”
Section: Discussionmentioning
confidence: 53%
“…Poor response to PDT was observed for doxorubicin concentrations and laser power density less than the relevant threshold values (Gao et al, 1997;Lanks et al, 1994). These results suggest that to achieve significant enhancement of drug cytotoxicity it is necessary to exceed the threshold power density and the duration time of irradiation attributed to the particular cell line.…”
Section: Discussionmentioning
confidence: 80%
“…Recovery, as evidenced by the appearance of substantial numbers of anaphase mitoses, could be detected as early as 4 h after the lowest intensity light exposure, but recovery after the highest intensity light exposure did not occur within the 24-h time frame of this experiment. Nevertheless, clonogenic survival (6) determined after 7-10 d of culture was unaffected, i.e., 100 + 20%, at all light doses used in these experiments (5).…”
Section: Resultsmentioning
confidence: 98%
“…L929 cells were maintained in polystyrene tissue culture dishes as previously described (5). Irradiation was performed in medium ~To whom co~espondence should be addressed.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation